Omniome Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
120
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$715M
- Investors
-
1
Omniome General Information
Description
Developer of a DNA sequencing platform designed to deliver unsurpassed sequencing accuracy. The company's offerings include sequencing by binding technology to provide enhanced precision of nucleotide and DNA matching, as well as leverages the natural matching ability of the polymerase, enabling researchers to provide accurate and fast results at low cost with the potential to advance cancer diagnostics.
Contact Information
Website
www.omniome.comCorporate Office
- 6965 Lusk Boulevard
- San Diego, CA 92121
- United States
Corporate Office
- 6965 Lusk Boulevard
- San Diego, CA 92121
- United States
Omniome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 20-Sep-2021 | $715M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series C) | 10-Jan-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 28-Jun-2018 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 29-May-2015 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 30-Sep-2014 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 13-Jun-2014 | Completed | Startup | |||
| 1. University Spin-Out | Completed | Startup |
Omniome Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series A2 | 8,873,967 | $0.000100 | 8% | $1.47 | $1.47 | 1x | $1.47 | 8.51% |
| Series A1 | 21,944,021 | $0.000100 | 8% | $0.9 | $0.9 | 1x | $0.9 | 21.04% |
Omniome Comparisons
Industry
Financing
Details
Omniome Competitors (21)
One of Omniome’s 21 competitors is Sphere Fluidics, a Formerly VC-backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sphere Fluidics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| DNAe | Formerly VC-backed | London, United Kingdom | ||||
| ToolGen | Formerly VC-backed | Seoul, South Korea | ||||
| Quantapore | Venture Capital-Backed | South San Francisco, CA | ||||
| Genewiz | Formerly VC-backed | South Plainfield, NJ |
Omniome Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Omniome Patents
Omniome Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021225886-A1 | Compositions and methods for modifying polymerase-nucleic acid complexes | Inactive | 05-May-2020 | ||
| WO-2021178467-A1 | Methods and compositions for sequencing double stranded nucleic acids | Inactive | 03-Mar-2020 | ||
| US-20230054204-A1 | Flow cells and methods for their manufacture and use | Active | 04-Feb-2020 | ||
| WO-2021158511-A1 | Flow cells and methods for their manufacture and use | Inactive | 04-Feb-2020 | ||
| WO-2021092431-A1 | Engineered polymerases for improved sequencing by binding | Inactive | 08-Nov-2019 | C12N9/1252 |
Omniome Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Omniome Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARCH Venture Partners | Venture Capital | Minority | ||
| ATEL Capital Group | Asset Manager | Minority | ||
| Altitude Life Science Ventures | Venture Capital | Minority | ||
| Biomatics Capital | Venture Capital | Minority | ||
| DCVC | Venture Capital | Minority |
Omniome FAQs
-
When was Omniome founded?
Omniome was founded in 2013.
-
Where is Omniome headquartered?
Omniome is headquartered in San Diego, CA.
-
What is the size of Omniome?
Omniome has 120 total employees.
-
What industry is Omniome in?
Omniome’s primary industry is Biotechnology.
-
Is Omniome a private or public company?
Omniome is a Private company.
-
What is the current valuation of Omniome?
The current valuation of Omniome is .
-
What is Omniome’s current revenue?
The current revenue for Omniome is .
-
How much funding has Omniome raised over time?
Omniome has raised $140M.
-
Who are Omniome’s investors?
ARCH Venture Partners, ATEL Capital Group, Altitude Life Science Ventures, Biomatics Capital, and DCVC are 5 of 16 investors who have invested in Omniome.
-
Who are Omniome’s competitors?
Sphere Fluidics, DNAe, ToolGen, Quantapore, and Genewiz are some of the 21 competitors of Omniome.
-
When was Omniome acquired?
Omniome was acquired on 20-Sep-2021.
-
Who acquired Omniome?
Omniome was acquired by Pacific BioSciences of California.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
